Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 13.19 is 15% below its 5-year average of 15.43, near the low end of its 5-year range (10.39–26.75).
As of the fiscal period ended Tuesday, June 30, 2026. 11.41% below its 12-month average of 14.88.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.19.
QUICK RATIO (ACID-TEST)
13.19
QUICK RATIO (ACID-TEST) AVG TTM
14.88
QUICK RATIO (ACID-TEST) AVG 3Y
14.43
QUICK RATIO (ACID-TEST) AVG 5Y
15.43
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.41%
CURRENT VS 3Y AVG
-8.64%
CURRENT VS 5Y AVG
-14.57%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+293.62%
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.24B
Quick Ratio (Acid-Test)
13.19
TTM Avg
14.88
3Y Avg
14.43
5Y Avg
15.43
Market Cap
$1.23B
Quick Ratio (Acid-Test)
15.25
TTM Avg
18.40
3Y Avg
18.04
5Y Avg
16.30
Market Cap
$1.22B
Quick Ratio (Acid-Test)
1.05
TTM Avg
1.06
3Y Avg
1.16
5Y Avg
1.68
Market Cap
$1.21B
Quick Ratio (Acid-Test)
14.91
TTM Avg
19.24
3Y Avg
24.35
5Y Avg
31.62
Market Cap
$1.20B
Quick Ratio (Acid-Test)
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.18B
Quick Ratio (Acid-Test)
1.41
TTM Avg
2.22
3Y Avg
2.73
5Y Avg
2.72
Market Cap
$1.31B
Quick Ratio (Acid-Test)
11.09
TTM Avg
7.43
3Y Avg
12.87
5Y Avg
13.91
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.24B | 13.19 | 14.88 | 14.43 | 15.43 |
| Omada Health (OMDA)vs › | $1.23B | 3.85 | 2.79 | 3.53 | 3.53 |
| Cronos Group Inc. (CRON)vs › | $1.23B | 15.25 | 18.40 | 18.04 | 16.30 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 1.05 | 1.06 | 1.16 | 1.68 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.21B | 14.91 | 19.24 | 24.35 | 31.62 |
| Kardigan, Inc. (KARD)vs › | $1.21B | 8.72 | 9.20 | 9.20 | 9.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 19.73 | 13.53 | 9.78 | 15.63 |
| MannKind Corporation (MNKD)vs › | $1.18B | 1.41 | 2.22 | 2.73 | 2.72 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | 11.09 | 7.43 | 12.87 | 13.91 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | 35.85 | 18.03 | 18.03 | 18.03 |
Quick Ratio
13.19
Excludes inventory
Current Ratio
13.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 13.19 |
| 2026-03-31 | 16.33 |
| 2025-12-31 | 14.13 |
| 2025-09-30 | 14.65 |
| 2025-06-30 | 16.13 |
| 2025-03-31 | 12.00 |
| 2024-12-31 | 10.56 |
| 2024-09-30 | 13.15 |
| 2024-06-30 | 15.08 |
| 2024-03-31 | 21.31 |
| 2023-12-31 | 10.39 |
| 2023-09-30 | 12.26 |
| 2023-06-30 | 18.46 |
| 2023-03-31 | 12.99 |
| 2022-12-31 | 13.68 |
| 2022-09-30 | 14.96 |
| 2022-06-30 | 18.72 |
| 2022-03-31 | 20.23 |
| 2021-12-31 | 15.87 |
| 2021-09-30 | 24.60 |
| 2021-06-30 | 26.75 |
| 2021-03-31 | 36.49 |
| 2020-12-31 | 32.96 |
| 2020-09-30 | 27.29 |
| 2020-06-30 | 34.48 |
| 2020-03-31 | 16.78 |
| 2019-12-31 | 16.81 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
